Dr Ulrich Rümenapp

Senior Biotech Program Lead at Bayer AG

Speaker

Dr. Rümenapp is based in Wuppertal, Germany and working within the Bayer Pharma Product Supply organization, where he is leading CMC development and partnering projects for biotech products, e.g., proteins, antibodies or antibody-drug-conjugates, including the transfer to external manufacturing partners, as well as strategic projects.
Prior to that, Dr. Rümenapp worked in Bayer Biologics Development and was Head of Projects in Biotech Contract Manufacturing, where he was responsible for contract manufacturing partnerships to ensure market supply.
Before it was acquired by Bayer, Dr. Rümenapp hold a similar position at Schering AG, and he started his career in the Production & Logistics department of Schering, being responsible for production aspects of licensing deals, due diligences, and product acquisitions of small molecule products and biologics.
Dr. Rümenapp studied chemistry and holds a Ph.D. in biosciences. He worked several years in academic biosciences research and as an assistant teacher in general pharmacology.